While ethanol is well established as a solvent and preservative in traditional small-molecule formulations, its applications extend far further. In biologics, vaccines and advanced therapies, ethanol plays a critical role in manufacturing processes, purification steps and stabilisation strategies. These uses highlight ethanol’s continued importance in modern pharmaceutical innovation.
Ethanol in Protein Purification
In biologics manufacturing, ethanol is integral to protein fractionation and purification processes:
- The Cohn process for plasma protein fractionation uses cold ethanol precipitation to separate proteins such as albumin and immunoglobulins
- Ethanol’s volatility allows controlled precipitation and recovery while minimising residual solvent in final products
- This technique remains a benchmark for plasma-derived therapeutics, ensuring purity and stability
Ethanol in Vaccine Formulation and Manufacture
Ethanol also features in the production of vaccines, both as a processing aid and as a stabiliser:
- Used in inactivation processes for certain viral vaccines
- Employed as a co-solvent in adjuvant systems or excipient blends to improve solubility of hydrophobic components
- Facilitates extraction and purification steps during antigen preparation
Its established safety profile makes ethanol a preferred choice where excipient familiarity with regulators is essential.
Ethanol as a Permeation and Stabilisation Agent
In advanced drug delivery systems, ethanol supports both permeation and stability:
- Transdermal patches: ethanol enhances penetration of APIs across the skin barrier
- Liposomal formulations: ethanol contributes to membrane fluidity and stabilisation during manufacture
Ethanol in Cell and Gene Therapy Processes
The emergence of cell and gene therapies has reinforced ethanol’s utility:
- Cryopreservation protocols: ethanol-based systems are employed in controlled freezing devices to regulate cooling rates
- Viral vector purification: ethanol precipitation aids concentration and purification of viral particles
- Analytical workflows: ethanol precipitation remains a standard technique in DNA and RNA sample preparation
Quality and Compliance Considerations
Because ethanol in these applications directly impacts biological product safety, regulators emphasise:
- Pharmaceutical grade, GMP-certified ethanol only — industrial grades are unsuitable due to impurity risks
- Residual solvent testing to ensure levels comply with ICH Q3C guidelines
- Traceability of production to guarantee consistent quality in complex biologics supply chains
Ethanol is not limited to traditional oral liquids or tablet coatings; it is embedded in the fabric of modern pharmaceutical innovation. From plasma proteins to mRNA vaccines and advanced cell and gene therapies, ethanol remains a critical enabler of biopharmaceutical manufacturing.
As the industry advances, the requirement for GMP-certified ethanol in these high-value applications is not just a regulatory expectation — it is a scientific necessity to ensure patient safety and therapeutic efficacy. At Kimia, we deliver GMP-certified ethanol that empowers innovation, supports compliance and builds confidence in every batch. Click here to discover how our pharmaceutical-grade solvents can strengthen your biologics and advanced therapy supply chain.